Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials
Grove AI’s technology uses voice agents to recruit eligible patients for clinical trials. Formed in 2024, the startup’s rapid growth led to its acquisition by Hippocratic AI earlier this year. The post Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials appeared first on MedCity News .
Record details
Published: 31 July 2026
Source: MedCity News AI
Category: News
Topics: Healthcare · Agents & autonomy
Retrieved: 1 August 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents
MedCity News AI · 4 August 2026
Meta AI uses a second AI agent as a memory coach to keep long tasks on track
The Decoder · 2 August 2026
The path to artificial superintelligence
MIT Technology Review · 27 July 2026
Assured Health Secures $19M to Get Providers In-Network Faster with Agentic AI
MedCity News AI · 23 July 2026
Humanoid robots set for explosive growth
ITWeb (ZA) · 21 July 2026
The world’s largest ‘biological datacenter’ could help make animal testing obsolete
Fast Company Tech · 13 August 2026
How to cite this record
ethics.ai (31 July 2026), “Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials,” evidence record 15476, https://ethics.ai/record/15476 (originally published by MedCity News AI).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.